RxDoctor Payments DataLook up a doctor →

Kevin Rauchut

Adult Health · West Hollywood, CANPI 1578084547

Payments from drug & device makers

$27,186in general payments, 2019–2025

Across 632 payments — averaging $43.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Gilead$7K
  • Merck$6K
  • Viiv Healthcare Company$4K
  • Theratechnologies Inc.$3K
  • AbbVie$916
  • Bausch Health US, LLC$661
  • plus $5K from 43 others

What the payments were for

  • Consulting fees$3,19012%
  • Speaking & faculty fees$4,61417%
  • Travel & lodging$4,42716%
  • Food & beverage$14,76954%
  • Education$1861%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$27,186 in reported general payments places this provider in the 95th percentile of 785 adult health providers in California.

See all adult health providers in California

Most prescribed under Part D

DrugClaimsCost to plans & patients
SerostimSomatropin25$498,739
BiktarvyBictegrav/Emtricit/Tenofov Ala97$365,997
SymtuzaDarunavir/Cob/Emtri/Tenof Alaf48$231,403
JulucaDolutegravir/Rilpivirine56$192,356
TivicayDolutegravir Sodium67$146,873
DescovyEmtricitabine/Tenofov Alafenam38$83,772
CabenuvaCabotegravir/Rilpivirine11$69,927
PrezcobixDarunavir/Cobicistat25$59,199
DovatoDolutegravir Sodium/Lamivudine17$47,510
MounjaroTirzepatide42$44,285
PifeltroDoravirine24$40,614
Nurtec OdtRimegepant Sulfate14$17,622
CaplytaLumateperone Tosylate11$17,186
OzempicSemaglutide18$16,563
Trelegy ElliptaFluticasone/Umeclidin/Vilanter27$16,019

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
EMD Serono, Inc.Serostim$544$498,73925 claims
Viiv Healthcare CompanyJuluca, Tivicay, Cabenuva, Dovato$4,407$456,666151 claims
GileadBiktarvy, Descovy$7,099$449,769135 claims
Janssen Products, LPSymtuza$169$231,40348 claims
Johnson & JohnsonPrezcobix$412$59,19925 claims
Lilly USA, LLCMounjaro, Trulicity$430$56,36355 claims
MerckPifeltro$5,790$40,61424 claims
PfizerNurtec Odt, Eliquis$41$28,85726 claims
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta$41$17,18611 claims
Novo NordiskOzempic$108$16,56318 claims
GSKTrelegy Ellipta$108$16,01927 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix, Vyvanse$99$12,20924 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 785 adult health providers in California.

Other adult health in West Hollywood

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →